MRD-guided treatment in multiple myeloma
Measurable residual disease (MRD) status is a valuable prognostic marker in multiple myeloma (MM), but questions still remain. Speaking from the 1st European Myeloma Network (EMN) Meeting, in Turin, I...
Author: VJHemOnc
Added: 07/25/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Myeloma